Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0070
-0.00052 (-6.91%)
At close: Jun 16, 2026
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $996.63 thousand as of June 16, 2026. Its market cap has decreased by -15.16% in one year.
Market Cap
996.63K
Enterprise Value
56.75M
Revenue
20.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 996.63K, a decrease of -99.54%. That is a compound annual growth rate of -47.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 927.71K | -22.92% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 1.47M |
| International Stem Cell | 1.36M |
| Neon Bloom | 1.27M |
| Abpro Holdings | 1.24M |
| Avenue Therapeutics | 1.05M |
| Burzynski Research Institute | 991.12K |
| Lyra Therapeutics | 976.19K |
| Protagenic Therapeutics | 904.20K |